Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebivolol in Hypertensive Patients With Coronary Arterial Spasm
NCT03930433Phase 4Completed
- Sponsor
- Korea University Anam Hospital
- Start
- Jan 2018
- Primary completion
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of nebivolol in Coronary vasospasm (CAS), hypertension (HTN), sponsored by Korea University Anam Hospital. Started Jan 2018; status: completed.
02
Drugs
nebivolol
03
Conditions
Coronary vasospasm (CAS)hypertension (HTN)
Beyond the preview
Go deeper on NCT03930433.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03930433.